摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-hydroxyquinoline-5,7-disulfonyl dichloride | 80949-46-8

中文名称
——
中文别名
——
英文名称
8-hydroxyquinoline-5,7-disulfonyl dichloride
英文别名
8-Hydroxyquinoline-5,7-disulfonyl chloride
8-hydroxyquinoline-5,7-disulfonyl dichloride化学式
CAS
80949-46-8
化学式
C9H5Cl2NO5S2
mdl
——
分子量
342.18
InChiKey
BKXTYTIMXVROBM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    19
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    118
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    8-hydroxyquinoline-5,7-disulfonyl dichloridepotassium carbonate 作用下, 以 四氢呋喃乙腈 为溶剂, 反应 5.0h, 生成 5,7-bis(N,N-dimethylaminosulfonyl)-8-methoxyquinoline
    参考文献:
    名称:
    Design and synthesis of 8-hydroxyquinoline-based radioprotective agents
    摘要:
    In radiation therapy, adverse side effects are often induced due to the excessive cell death that occurs in radiosensitive normal cells. The radiation-induced cell death of normal cells is caused, at least in part, by apoptosis, which undergoes via activation of p53 and increase in the p53 protein, a zinc-containing transcriptional factor, in response to cellular damage. Therefore, radioprotective drugs that can protect normal cells from radiation and thus suppress adverse side effects would be highly desirable. We report herein on the radioprotective activity of 8-hydroxyquinoline (8HQ) derivatives that were initially designed so as to interact with the Zn2+ in p53. Indeed, the 5,7-bis(methylaminosulfonyl)-8HQ and 8-methoxyquinoline derivatives considerably protected MOLT-4 cells against gamma-ray radiation (10 Gy), accompanied by a low cytotoxicity. However, mechanistic studies revealed that the interaction of these drugs with p53 is weak and the mechanism for inhibiting apoptosis appears to be different from that of previously reported radioprotectors such as bispicen, which inhibits apoptosis via the denaturation of p53 as well as by blocking both transcription-dependent and -independent apoptotic pathways. (C) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2014.06.017
  • 作为产物:
    描述:
    8-羟基喹啉氯磺酸 作用下, 反应 0.33h, 以55%的产率得到8-hydroxyquinoline-5,7-disulfonyl dichloride
    参考文献:
    名称:
    WO2008/129276
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • TSIRULE, M. A.;BANKOVSKIJ, YU. A.;BRUSILOVSKIJ, P. I., IZV. AN LATVSSR. CEP. XIM., 1981, N 6, 733-736
    作者:TSIRULE, M. A.、BANKOVSKIJ, YU. A.、BRUSILOVSKIJ, P. I.
    DOI:——
    日期:——
  • [EN] DISULFONAMIDES USEFUL IN THE TREATMENT OF INFLAMMATION<br/>[FR] DISULFONAMIDES UTILES DANS LE TRAITEMENT DE L'INFLAMMATION
    申请人:BOEHRINGER INGELHEIM INT
    公开号:WO2008129276A1
    公开(公告)日:2008-10-30
    [EN] There is provided compounds of formula (I), wherein the A ring, X1, X2, R1, R2, Cx, Qy, T1 and T2 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation.
    [FR] L'invention porte sur des composés de formule (I), dans laquelle le noyau A, X1, X2, R1, R2, Cx, Qy, T1 et T2 ont des significations données dans la description, et sur des sels pharmaceutiquement acceptables de celles-ci. Ces composés sont utiles dans le traitement de maladies dans lesquelles l'inhibition de l'activité d'un élément de la famille du MAPEG est souhaitée et/ou requise, et, en particulier, dans le traitement de l'inflammation.
  • Design and synthesis of 8-hydroxyquinoline-based radioprotective agents
    作者:Shinya Ariyasu、Akiko Sawa、Akinori Morita、Kengo Hanaya、Misato Hoshi、Ippei Takahashi、Bing Wang、Shin Aoki
    DOI:10.1016/j.bmc.2014.06.017
    日期:2014.8
    In radiation therapy, adverse side effects are often induced due to the excessive cell death that occurs in radiosensitive normal cells. The radiation-induced cell death of normal cells is caused, at least in part, by apoptosis, which undergoes via activation of p53 and increase in the p53 protein, a zinc-containing transcriptional factor, in response to cellular damage. Therefore, radioprotective drugs that can protect normal cells from radiation and thus suppress adverse side effects would be highly desirable. We report herein on the radioprotective activity of 8-hydroxyquinoline (8HQ) derivatives that were initially designed so as to interact with the Zn2+ in p53. Indeed, the 5,7-bis(methylaminosulfonyl)-8HQ and 8-methoxyquinoline derivatives considerably protected MOLT-4 cells against gamma-ray radiation (10 Gy), accompanied by a low cytotoxicity. However, mechanistic studies revealed that the interaction of these drugs with p53 is weak and the mechanism for inhibiting apoptosis appears to be different from that of previously reported radioprotectors such as bispicen, which inhibits apoptosis via the denaturation of p53 as well as by blocking both transcription-dependent and -independent apoptotic pathways. (C) 2014 Elsevier Ltd. All rights reserved.
  • WO2008/129276
    申请人:——
    公开号:——
    公开(公告)日:——
查看更多